Assets B.E. 2547 (2004), as amended from time to time, (the “Notifications on Acquisition and Disposition”), having the largest size of the transaction of 0.19% of the total value of consideration

million approximately. The size of this transaction equals 24.55% of the Total Assets of UAC, calculated from Consolidated Statements of Financial Position as of December 31, 2018. Details of the

SBLC facility. Transaction Size*: The aforementioned transaction is considered as the receipt of financial assistance. The size of the transaction is approximately 0.17 percent of the Company’s Net

size of the Transaction is calculated to be at the highest of 5.43% pursuant to the Comparison of Consideration Paid criteria (calculated from the reviewed consolidated financial statements of the

coupon 2.51% 2.63% 3.15% 3.57% 3.86% Issue size (MB) 1,000 1,300 3,000 2,700 5,000 13,000 1 Demand (MB) 9,570 10,017 7,291 5,179 9,986 42,043 Bid Coverage Ratio 8.41x IRR 3.58 % p.a Weighted Avg Cost 3.41

revenue has continuously grown mainly due to its greater expansion of laboratory scopes of testing and analyzing for agricultural, food, and pharmaceutical associated with continual growing number of

274.87 Shareholder’s equity (58.02) (59.65) (61.32) Revenue 2.32 0.02 0.01 Expenses 3.51 1.64 1.69 Net Profit/(Loss) (1.18) (1.63) (1.67) 4. Calculation of Transaction Size For the acquisition of Leyland’s

Company in the past six months the cumulative transaction size is still lower than 15 percent also. The Company certifies that this information is true and correct and has been compiled with prudence and

or Disposal of Assets, 2004 as the size of the transaction was 0.31% calculated via the value of securities for the assets acquired which was the highest criteria but still less than 15% (base on

the period ended 30 June 2017. The transaction value is higher than 0.03% but below 3% of the net tangible asset value. Given the size of the transaction, the Board of Directors’ approval is required